Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The evolution of beta-agonists.

R Aranson1, J L Rau

  • 1Department of Medicine, Emory University School of Medicine, Medical Intensive Care Unit and Respiratory Therapy Department, Grady Memorial, Georgia State University, Atlanta 30303-3083, USA.

Respiratory Care Clinics of North America
|November 24, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Introduction of a single isomer beta agonist.

Respiratory care·2000
Same author

New horizons in respiratory care: the pharmacology of inhaled aerosol drug therapy.

Respiratory care·2000
Same author

Inhaled adrenergic bronchodilators: historical development and clinical application.

Respiratory care·2000
Same author

Combining a positive expiratory pressure device with a metered-dose inhaler reservoir system using chlorofluorocarbon albuterol and hydrofluoroalkane albuterol: effect on dose and particle size distributions.

Respiratory care·2000
Same author

Recent developments in respiratory care pharmacology.

Journal of perianesthesia nursing : official journal of the American Society of PeriAnesthesia Nurses·1999
Same author

Reservoir design and dose availability with long-term metered dose inhaler corticosteroid use.

Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine·1999
Same journal

Indirect calorimetry: relevance to patient outcome.

Respiratory care clinics of North America·2006
Same journal

Indirect calorimetry: applications in practice.

Respiratory care clinics of North America·2006
Same journal

Strategies to prevent aspiration-related pneumonia in tube-fed patients.

Respiratory care clinics of North America·2006
Same journal

Feeding the critically ill obese patient: the role of hypocaloric nutrition support.

Respiratory care clinics of North America·2006
Same journal

Nutrition support for the long-term ventilator-dependent patient.

Respiratory care clinics of North America·2006
Same journal

A nutritional strategy to improve oxygenation and decrease morbidity in patients who have acute respiratory distress syndrome.

Respiratory care clinics of North America·2006
See all related articles

Inhaled beta-agonists are key for treating reactive airway diseases. Their development, mechanisms, and classification into four duration classes offer new therapeutic insights.

Area of Science:

  • Pharmacology
  • Respiratory Medicine

Background:

  • Inhaled beta-agonists are primary bronchodilator treatments for reactive airway diseases.
  • Understanding bronchoconstriction and bronchodilation physiology has evolved over centuries.

Observation:

  • The discovery of the beta-adrenoceptor has significantly advanced the understanding of beta-agonist mechanisms.
  • Three main classes of beta-agonists exist: catecholamines, resorcinols, and saligenins.

Findings:

  • This review details the chemical structures, receptor interactions, and effects of common beta-agonists.
  • Analysis of duration of action suggests a new classification: ultrashort, short, intermediate, and long-acting.

Implications:

  • This classification may refine therapeutic strategies for reactive airway diseases.

Related Experiment Videos

  • Further research into beta-agonist duration can optimize patient treatment and outcomes.